|
|
Analysis on pathogenic bacteria and drug resistance of infective endocarditis in a third grade hospital |
WANG Bo1 DING Guo-feng2▲ |
1. Binzhou Medical University, Shandong Province, Binzhou 256603, China;
2. Department of Infection,Binzhou Medical University Hospital, Shandong Province, Binzhou 256603, China |
|
|
Abstract Objective To explore the pathogenic bacteria and drug resistance of infective endocarditis, and to provide references for clinicians to apply antibiotics rationally. Methods A total of 107 inpatients with infective endocarditis(infective endocarditis) in a third-class hospital from June 1, 2014 to May 31, 2019 were selected for retrospective analysis, and 79 cases were selected for blood bacterial culture and drug sensitivity test. The pathogenic bacteria composition and drug resistance distribution in clinical data were analyzed. Results In 107 patients with infective endocarditis, 79 strains of non-duplicative pathogens were detected, including 75 strains of gram-positive bacteria(94.94%), including 31 strains of streptococcus (accounting for 39.24%), 22 strains of Staphylococcus aureus (accounting for 27.85%), and 4 strains of gram-negative bacteria (accounting for 5.06%), no cases of fungal infection were detected. Streptococcus was still the most common pathogenic bacteria (39.24%). Drug resistance analysis was showed that the drug resistance rate of Streptococcus bacteria to Penicillin was 90.32%. Of the 22 strains of Staphylococcus bacteria, 20 strains were resistant to Penicillin, and the drug resistance rate of Benzoxicillin was 81.82%. However, it was sensitive to antibiotics of special use grade, such as Vancomycin, Imipenem and Linezolid, and had no resistance.Conclusion The pathogenic bacteria of infective endocarditis are mainly gram-positive bacteria, and Streptococcus is still the most common. Gram-positive cocci are generally resistant to Penicillin. In order to ensure the efficacy and safety of antiinfective treatment, antibacterials should be selected empirically in combination with the local etiological data, and the drug regimen should be adjusted in time according to the results of drug susceptibility test.
|
|
|
|
|
[1] |
葛均波,徐永健,王辰.内科学[M].9 版.北京:人民卫生出版社,2019:321-327.
|
[2] |
Li JS,Sexton DJ,Mick N,et al.Proposed modifications to the Duke criteria for the diagnosis of infective endocarditis[J].Clin Infect Dis,2000,30(4):633-638.
|
[3] |
Eleonora W,Ai QY,José ME,et al.New concepts in the pathophysiology of infective endocarditis[J].Curr Infect Dis Rep,2006,8(4):271-279.
|
[4] |
Lee A,Mirrett S,Reller LB,et al.Detection of bloodstream infections in adults: how many blood cultures are needed?[J].Clin Microbiol,2007,45(11):3546-3548.
|
[5] |
Cockerill FR 3rd,Wilson JW,Vetter EA,et al.Optimal testing parameters for bloodcultures[J].Clin Infect Dis,2004,38(12):1724-1730.
|
[6] |
张健瑜,杨超,梁茜,等.79 例感染性心内膜炎临床分析[J].中华医药感染学杂志,2013,23(9):2045-2047.
|
[7] |
Cahill TJ,Prendergast BD.Infective endocarditis[J].Lancet,2016,387(10021):882-893.
|
[8] |
景增秀,康桂兰,魏秀邦,等.2014-2017年感染性心内膜炎患者分离出病原菌分布及流行特点[J].中国病原生物学杂志,2019,14(2):203-207,212.
|
[9] |
黄德仪,林蔡弟,蒯魏,等.感染性心内膜炎患者的血培养病原菌分布及耐药性分析[J].中国抗生素杂志,2020,45(2):170-174.
|
[10] |
宋雅信.68 例活动期感染性心内膜炎患者血菌培养结果及其对抗菌药物的耐药性分析[J].抗感染药学,2019,16(10):1715-1717.
|
[11] |
王佳,高辉,徐益,等.感染性心内膜炎患者病原菌分布及耐药性分析[J].中国抗生素杂志,2019,44(8):958-962.
|
[12] |
简劲峰,封加涛,叶华安,等.78 例感染性心内膜炎外科治疗的体会[J].国际感染病学(电子版),2019,8(3):20-21.
|
[13] |
冀元元.亚急性感染性心内膜炎45 例临床诊治分析[J].中国当代医药,2012,19(30):174,176.
|
[14] |
Duval X,Millot S,Tubiana S.Prevention of Infective endocarditis[J].Press Med,2019,48(5):556-562.
|
[15] |
Cahill TJ,Baddour LM,Habib G,et al.Challenges in Infective Endocarditis[J].J Am Coll Cardiol,2017,69(3):325-344.
|
|
|
|